Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a case report
https://doi.org/10.14341/probl8636
Abstract
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) is an autosomal recessive mitochondrial fatty acid beta-oxidation disorder with variable presentation including lack of energy (lethargy), low blood sugar (hypoglycemia), weak muscle tone (hypotonia), hepatic steatosis, and hypocarnitinemia. In this report, we describe a 9-month-old male patient who suffered from recurrent hypoglycemia with hypoglycemic convulsions, vomiting, and neurological regression since the age of 4 months. The patient presented with hypotonia, motor delay, hepatomegaly, protein-energy malnutrition (BMI SDS — 2.8). Biochemical tests demonstrated hypoglycemia (2.5 mmol/l), elevated lactate, creatine phosphokinase, and aminotransferases. There were also increased concentrations of long-chain acylcarnitine and 3-hydroxyacylcarnitine as well as a dramatic decrease in the carnitine level. Digestive tract malformations, endocrinopathies, and degenerative diseases of the nervous system were excluded hydroxyacyl-CoA dehydrogenase (HADHA) gene)testing revealed a homozygous mutation p.Glu474Gln. This confirmed the diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Diet correction by adding medium chain triglycerides, compensation of carnitine deficiency, and symptomatic therapy made it possible to avoid fatal metabolic crises and manage neurological regression. Early detection, diagnosis, and treatment of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency may improve clinical outcomes.
About the Authors
Elena B. KhramovaTyumen State Medical University
Russian Federation
MD, PhD, assistant professor
Elena Yu. Khorosheva
Tyumen State Medical University
Russian Federation
MD, PhD
Olga V. Perfilova
Regional Clinical Hospital №1
Russian Federation
MD
References
1. Al-Thihli K, Sinclair G, Sirrs S, et al. Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid beta-oxidation disorders in adult patients with rhabdomyolysis. J Inherit Metab Dis. 2014;37(2):207-213. doi: 10.1007/s10545-012-9578-7
2. Berardo A, DiMauro S, Hirano M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep. 2010;10(2):118-126. doi: 10.1007/s11910-010-0096-4
3. Diekman EF, van Weeghel M, Wanders RJ, et al. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models. FASEB J. 2014;28(7):2891-2900. doi: 10.1096/fj.14-250241
4. Oliveira SF, Pinho L, Rocha H, et al. Rhabdomyolysis as a presenting manifestation of very long-chain acyl-coenzyme a dehydrogenase deficiency. Clin Pract. 2013;3(2):e22. doi: 10.4081/cp.2013.e22
5. Tenopoulou M, Chen J, Bastin J, et al. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency. J Biol Chem. 2015;290(16):10486-10494. doi: 10.1074/jbc.M114.635102
Supplementary files
Review
For citations:
Khramova E.B., Khorosheva E.Yu., Perfilova O.V. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a case report. Problems of Endocrinology. 2018;64(3):160-162. https://doi.org/10.14341/probl8636

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).